Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Derecho penal
893
Procedimiento penal
534
Leyes y legislación
415
Administración de justicia penal
142
Historia
141
Delitos
74
Juicio oral
65
Criminología
59
Amparo
49
Responsabilidad penal
48
Prisiones
45
Derecho
43
Sistema acusatorio
40
Filosofía
39
Prueba penal
38
Derechos humanos
37
Penas
37
Política y gobierno
34
México
30
Situación legal
28
Derechos civiles
27
Administración de justicia
25
Procedimiento civil
25
Filosofía del derecho penal
24
Derecho constitucional
23
Derecho procesal
23
Jurisprudencia
22
Procesos (Derecho)
22
Aspectos sociales
21
Delitos internacionales
20
-
161461por Wang, Xin-Cai, Gao, Shang-Jun, Zhuo, Shi-Long, Weng, Cui-Lian, Feng, Hang-Wei, Lin, Jian, Lin, Xing-Sheng, Huang, Long“…One hundred and fifty-five patients were enrolled with sTBI admitted to the hospital between January 2016 and December 2020 and divided them into a CCS group (n = 75) and a non-CCS group (n = 80) based on the presence of CCS. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161462por Mehta, Sandhya, Ghosh, Sabyasachi, Sander, Stephen, Kuti, Effie, Mountford, William K.“…The population was divided into 2 cohorts (with and without a history of CVD) and followed until the end of their enrollment coverage, death, or 12 months, whichever came first. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161463por Su, Bin, Gao, Guiju, Wang, Min, Lu, Yanqiu, Li, Linghua, Chen, Chen, Chen, Yuanyuan, Song, Chuan, Yu, Fengting, Li, Ying, Liu, Yixin, Luo, Yang, He, Haolan, Cheng, Cong, Xu, Lixia, Zhang, Tong, Sun, Lijun, Liu, An, Xia, Wei, Qin, Yuanyuan, Zhao, Qingxia, Wei, Hongxia, Cai, Weiping, Chen, Yaokai, Zhang, Fujie, Wu, Hao“…FINDINGS: Between November 27, 2018 and March 11, 2021, a total of 826 participants were screened, and 630 were finally enrolled and randomly assigned (1:1) to either ANV (n = 315) or EFV (n = 315) groups. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161464por Seifeldin, Raafat“…RESULTS: A total of 690 patients were enrolled in this study; 437 (63.4%) received oxycodone HCl controlled- release and 253 (36.6%) received transdermal fentanyl. …”
Publicado 2003
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161465por Iyengar, Reethi N., Balagere, Dhanur S., Henderson, Rochelle R., LeFrancois, Abbey L., Rabbitt, Rebecca M., Frazee, Sharon Glave“…Continuously eligible Medicare Part D beneficiaries (Medicare Advantage and prescription drug plans participants only) aged 65 years or older who had an antidiabetic, antihypertensive, or antihyperlipidemic prescription claim between October and December 2010, were identified and followed for the next 2 years. Those enrolled in a home delivery auto refill program were excluded from this analysis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161466por Gleason, Patrick P., Phillips, Jill, Fenrick, Beckie A., Delgado-Riley, Ana, Starner, Catherine I.“…Members in both groups were required to be continuously enrolled from August 1, 2010, through January 31, 2011. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161467por Kunze, April M., Gunderson, Brent W., Gleason, Patrick P., Heaton, Alan H., Johnson, Steven V.“…The 9 million members are beneficiaries of 10 Blue Cross Blue Shield (BCBS) health plans distributed throughout the United States and the subset of 1.8 million members are enrolled in 1 BCBS health plan in the Northern Plains states. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161468por Barnett, Mitchel, Frank, Jessica, Wehring, Heidi, Newland, Brand, VonMuenster, Shannon, Kumbera, Patty, Halterman, Tom, Perry, Paul J.“…The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA 2003) and the subsequent implementation of Medicare Part D in January 2006 for the more than 20 million Medicare beneficiaries enrolled in the Part D benefit formalized MTM services for a subset of high-cost patients. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161469por Stratton-Loeffler, Moxie J., Lo, Joan C., Hui, Rita L., Coates, Ashley, Minkoff, Jerome R., Budayr, Amer“…Patients were required to be continuously enrolled for 12 months before and 6 months after ergocalciferol initiation. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161470por Cinza-Estévez, Zurina, Resik-Aguirre, Sonia, Figueroa-Baile, Nelvis L., Oquendo-Martínez, Rachel, Campa-Legrá, Ivan, Tejeda-Fuentes, Alina, Rivero-Caballero, Marila, González-García, Gloria, Chávez-Chong, Cristina O., Alonso-Valdés, Marel, Hernández-Bernal, Francisco, Lemos-Pérez, Gilda, Campal-Espinosa, Ana, Freyre-Corrales, Giselle, Benítez-Gordillo, Delia, Gato-Orozco, Evelyn, Pérez Bartutis, Greter Susana, Mesa-Pedroso, Iliana, Bueno-Alemani, Nilda, Infante-Aguilar, Elizabeth, Rodríguez Reinoso, José Luis, Melo-Suarez, Grettel, Limonta-Fernández, Miladys, Ayala-Ávila, Marta, Muzio-González, Verena L.“…FINDINGS: Between July 15, 2021, and August 16, 2021, 644 paediatric subjects were screened, of whom 592 were enrolled after verifying that they met the selection criteria: firstly 88 were included in Phase 1 of the study and 504 who completed Phase 2. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161471“…RESULTS: Of the planned 300 participants, a total of 188 participants (mean [SD] age, 49.1 [12.5] years; 102 [54%] female) were enrolled before the trial was stopped because of the COVID-19 pandemic. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161472por Song, Joon Young, Choi, Won Suk, Heo, Jung Yeon, Kim, Eun Jin, Lee, Jin Soo, Jung, Dong Sik, Kim, Shin-Woo, Park, Kyung-Hwa, Eom, Joong Sik, Jeong, Su Jin, Lee, Jacob, Kwon, Ki Tae, Choi, Hee Jung, Sohn, Jang Wook, Kim, Young Keun, Yoo, Byung Wook, Jang, In-Jin, Capeding, Maria Z., Roman, François, Breuer, Thomas, Wysocki, Piotr, Carter, Lauren, Sahastrabuddhe, Sushant, Song, Manki, D'Cor, Naveena, Kim, Hun, Ryu, Ji Hwa, Lee, Su Jeen, Park, Yong Wook, Cheong, Hee Jin“…FINDINGS: Between 30 August 2021 and 11 January 2022, a total of 4913 participants were screened and 4036 participants (1956 in Cohort 1 and 2080 in Cohort 2) who met eligibility criteria were enrolled and randomised to receive 2 doses of GBP510/AS03 (n = 3039) or ChAdOx1-S (n = 997). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161473por Caruso, Irene, Di Gioia, Ludovico, Di Molfetta, Sergio, Cignarelli, Angelo, Palmer, Suetonia Cressida, Natale, Patrizia, Strippoli, Giovanni F.M., Perrini, Sebastio, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco“…METHODS: In this network meta-analysis, we searched PubMed, MEDLINE, and Web of Science (from database inception to June 24, 2023) for randomised controlled studies, published in English, that enrolled individuals with type 2 diabetes treated with tirzepatide, iGlarLixi, iDegLira, GLP-1RA plus SGLT-2i combination, or high-dose GLP-1RA (dulaglutide 3 mg and 4.5 mg, semaglutide 2 mg) compared with placebo or active comparators. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161474por Boige, Valérie, Blons, Hélène, François, Eric, Ben Abdelghani, Meher, Phelip, Jean-Marc, Le Brun-Ly, Valerie, Mineur, Laurent, Galais, Marie Pierre, Villing, Anne-Laure, Hautefeuille, Vincent, Miglianico, Laurent, De La Fouchardière, Christelle, Genet, Dominique, Levasseur, Nadia, Levaché, Charles-Briac, Penel, Nicolas, Mitry, Emmanuel, Jacquot, Stéphane, Aparicio, Thomas, Brument, Emilie, Gourgou, Sophie, Castan, Florence, Bouché, Olivier“…RESULTS: Of 214 patients enrolled (141 men [65.9%]; median age, 67 years [range, 23-85 years]), 139 were randomized to receive cetuximab (n = 67; 45 men [67.2%]; median age, 64 years [range, 34-85 years]) or to be observed (n = 72; 50 men [69.4%]; median age, 68 years [23-85 years]). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161475por Foss de Freitas, Maria Cristina, DillGomes, Anabela, Neidert, Adam, Podgrabinska, Simona, Olenchock, Ben, SinhaRoy, Rababir, Harris, Charles Andrew, Akinci, Baris, Altarejos, Judith, Oral, Elif A“…Here we report the long-term follow-up of a 21- year-old female patient with atypical partial lipodystrophy who developed neutralizing antibodies after treatment with metreleptin and was enrolled in a compassionate use protocol (IND No. 144013) with a leptin receptor agonist (mibavademab) after observing no benefit from setmelanotide (a melanocortin 4 receptor-agonist). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161476“…A total of 298 women were enrolled in which demographic, anthropometric characteristics, blood pressure (BP), use of hormone therapy (HT), physical activity (PA), smoking status, alcohol intake were obtained. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161477por Mendell, Jeanne, Wang, Yuhuan, Olenchock, Ben A, Podgrabinska, Simona, Pagovich, Odelya E, Oral, Elif A, Brown, Rebecca J, Davis, John“…Results: Sixteen patients were enrolled with median body weight (BW) of 51 kg, corresponding to the approximate BW cut point for mibavademab. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161478por Su, Guan-Yu, Yeh, Chang-Ching, Yang, Chen-Chang, Hwu, Chii-Min, Chen, Harn-Shen, Wang, Fan-Fen, Jui Huang, Chun“…Results: A total of 211 women were enrolled and the derived early-trimester upper limit of serum TSH (median: 0.92 [0.007-3.08] uIU/mL) was lower than the value provided by the manufacturer (0.27-4.2 uIU/mL), while the upper limit of free T4 (median: 1.28 [0.93-2.15] ng/dL) and free T3 (3.00 [2.30-5.10]ng/dL) were both higher than the non-pregnant value (0.93-1.7 ng/dL and 2.0-4.4 ng/dL, respectively). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161479por Roth, Christian L, Shoemaker, Ashley H, Gottschalk, Michael, Miller, Jennifer, Yuan, Guojun, Malhotra, Sonali, Scimia, Cecilia, Jennifer Abuzzahab, M“…Methods: Patients aged ≥6 to ≤40 years with documented evidence of HO were enrolled in an open-label Phase 2 trial (NCT04725240) and received setmelanotide once daily for 16 weeks. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
161480por Maraka, Spyridoula, Owen, Richard, Ospina, Naykky Maruquel Singh, Knox, Micheal, Dodds, Terri, Spencer, Horace, Dishongh, Katherine, Albashaireh, Arwa, Shah, Aashka, Syed, Sabah, Naqvi, Syeda, Motahari, Hooman, Thumma, Soumya, Ambrogini, Elena, Pablo Brito, Juan“…Results: Fifty participants were enrolled (33% recruitment rate); 24 were randomized to the LT4 and 26 to the discontinuation group. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto